Lisa Wheeler

4.5k total citations · 1 hit paper
31 papers, 2.4k citations indexed

About

Lisa Wheeler is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Lisa Wheeler has authored 31 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Oncology. Recurrent topics in Lisa Wheeler's work include Pulmonary Hypertension Research and Treatments (26 papers), Medical Imaging and Pathology Studies (8 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers). Lisa Wheeler is often cited by papers focused on Pulmonary Hypertension Research and Treatments (26 papers), Medical Imaging and Pathology Studies (8 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers). Lisa Wheeler collaborates with scholars based in United States, United Kingdom and France. Lisa Wheeler's co-authors include James E. Loyd, John A. Phillips, John H. Newman, Ivan M. Robbins, Eric D. Austin, William C. Nichols, Kirk B. Lane, Joy D. Cogan, Lora K. Hedges and Rizwan Hamid and has published in prestigious journals such as New England Journal of Medicine, Circulation and Nature Genetics.

In The Last Decade

Lisa Wheeler

30 papers receiving 2.3k citations

Hit Papers

Clinical and Molecular Genetic Features of Pulmonary Hype... 2001 2026 2009 2017 2001 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Clinical and Molecular Genetic Features of Pulmonary Hypertension in Patients with Hereditary Hemorrhagic Telangiectasia
    2001 518 citations James E. Loyd, Marc Humbert et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisa Wheeler United States 22 2.1k 776 557 364 244 31 2.4k
A. Morganti United States 13 1.7k 0.8× 622 0.8× 248 0.4× 221 0.6× 234 1.0× 26 2.5k
Michael V. Di Maria United States 15 955 0.5× 185 0.2× 63 0.1× 471 1.3× 278 1.1× 40 1.7k
Vladimir Y. Bogdanov United States 22 148 0.1× 406 0.5× 276 0.5× 727 2.0× 254 1.0× 58 2.0k
Yoichi Kameda Japan 24 741 0.4× 262 0.3× 32 0.1× 453 1.2× 541 2.2× 106 1.7k
Marc Hilhorst Netherlands 16 753 0.4× 77 0.1× 225 0.4× 382 1.0× 81 0.3× 34 1.5k
John D. Bonnet United States 22 264 0.1× 118 0.2× 149 0.3× 620 1.7× 202 0.8× 41 1.7k
Eva Honsová Czechia 19 283 0.1× 76 0.1× 65 0.1× 230 0.6× 235 1.0× 73 1.3k
Sylvia Bellucci France 22 231 0.1× 130 0.2× 884 1.6× 473 1.3× 159 0.7× 80 2.1k
J L Francis United States 19 201 0.1× 191 0.2× 113 0.2× 275 0.8× 187 0.8× 38 1.2k
C Glanzmann Switzerland 18 433 0.2× 73 0.1× 107 0.2× 316 0.9× 253 1.0× 67 1.2k

Countries citing papers authored by Lisa Wheeler

Since Specialization
Citations

This map shows the geographic impact of Lisa Wheeler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Wheeler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Wheeler more than expected).

Fields of papers citing papers by Lisa Wheeler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Wheeler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Wheeler. The network helps show where Lisa Wheeler may publish in the future.

Co-authorship network of co-authors of Lisa Wheeler

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Wheeler. A scholar is included among the top collaborators of Lisa Wheeler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Wheeler. Lisa Wheeler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tian, Xuefei, Mario Boehm, Kazuya Miyagawa, et al.. (2018). FHIT , a Novel Modifier Gene in Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 199(1). 83–98. 30 indexed citations
2.
Gaskill, Christa, Swapna Menon, Lora K. Hedges, et al.. (2016). Shared Gene Expression Patterns in Mesenchymal Progenitors Derived from Lung and Epidermis in Pulmonary Arterial Hypertension: Identifying Key Pathways in Pulmonary Vascular Disease. Pulmonary Circulation. 6(4). 483–497. 19 indexed citations
3.
Hemnes, Anna R., Aaron W. Trammell, Stephen L. Archer, et al.. (2014). Peripheral Blood Signature of Vasodilator-Responsive Pulmonary Arterial Hypertension. Circulation. 131(4). 401–409. 59 indexed citations
4.
Brittain, Evan L., David R. Janz, Eric D. Austin, et al.. (2014). Elevation of Plasma Cell-Free Hemoglobin in Pulmonary Arterial Hypertension. CHEST Journal. 146(6). 1478–1485. 38 indexed citations
5.
Brittain, Evan L., Meredith E. Pugh, Eric D. Austin, et al.. (2014). Impact of Diabetes on Survival and Right Ventricular Compensation in Pulmonary Arterial Hypertension. Pulmonary Circulation. 4(2). 311–318. 57 indexed citations
6.
Brittain, Evan L., Meredith E. Pugh, Lisa Wheeler, et al.. (2013). PROSTANOIDS BUT NOT ORAL THERAPIES IMPROVE RIGHT VENTRICULAR FUNCTION IN PULMONARY ARTERIAL HYPERTENSION. Journal of the American College of Cardiology. 61(10). E2119–E2119. 4 indexed citations
7.
Brittain, Evan L., Meredith E. Pugh, Lisa Wheeler, et al.. (2013). Prostanoids But Not Oral Therapies Improve Right Ventricular Function in Pulmonary Arterial Hypertension. JACC Heart Failure. 1(4). 300–307. 35 indexed citations
8.
Brittain, Evan L., Meredith E. Pugh, Lisa Wheeler, et al.. (2013). Shorter Survival in Familial versus Idiopathic Pulmonary Arterial Hypertension is Associated with Hemodynamic Markers of Impaired Right Ventricular Function. Pulmonary Circulation. 3(3). 589–598. 27 indexed citations
9.
Larkin, Emma K., John H. Newman, Eric D. Austin, et al.. (2012). Longitudinal Analysis Casts Doubt on the Presence of Genetic Anticipation in Heritable Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 186(9). 892–896. 148 indexed citations
10.
Newman, John H., Timothy N. Holt, Lora K. Hedges, et al.. (2011). High‐Altitude Pulmonary Hypertension in Cattle (Brisket Disease): Candidate Genes and Gene Expression Profiling of Peripheral Blood Mononuclear Cells. Pulmonary Circulation. 1(4). 462–469. 42 indexed citations
11.
Austin, Eric D., John A. Phillips, Joy D. Cogan, et al.. (2009). Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertension. Respiratory Research. 10(1). 87–87. 81 indexed citations
12.
Austin, Eric D., Joy D. Cogan, James West, et al.. (2009). Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females. European Respiratory Journal. 34(5). 1093–1099. 151 indexed citations
13.
Phillips, John A., Justin Poling, Charles Phillips, et al.. (2008). Synergistic heterozygosity for TGFβ1 SNPs and BMPR2 mutations modulates the age at diagnosis and penetrance of familial pulmonary arterial hypertension. Genetics in Medicine. 10(5). 359–365. 50 indexed citations
14.
Cogan, Joy D., Michael W. Pauciulo, Melissa Prince, et al.. (2006). High Frequency of BMPR2 Exonic Deletions/Duplications in Familial Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 174(5). 590–598. 151 indexed citations
15.
Ihida‐Stansbury, Kaori, David McKean, Kirk B. Lane, et al.. (2006). Tenascin-C is induced by mutated BMP type II receptors in familial forms of pulmonary arterial hypertension. American Journal of Physiology-Lung Cellular and Molecular Physiology. 291(4). L694–L702. 52 indexed citations
16.
Newman, John H., James E. Loyd, Ivan M. Robbins, et al.. (2005). Serotonin Transporter Polymorphisms in Familial and Idiopathic Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 173(7). 798–802. 69 indexed citations
17.
Runo, James, Cindy L. Vnencak‐Jones, Melissa Prince, et al.. (2003). Pulmonary Veno-occlusive Disease Caused by an Inherited Mutation in Bone Morphogenetic Protein Receptor II. American Journal of Respiratory and Critical Care Medicine. 167(6). 889–894. 95 indexed citations
18.
Newman, John H., Lisa Wheeler, Kirk B. Lane, et al.. (2001). Mutation in the Gene for Bone Morphogenetic Protein Receptor II as a Cause of Primary Pulmonary Hypertension in a Large Kindred. New England Journal of Medicine. 345(5). 319–324. 263 indexed citations
19.
Nichols, William C., Daniel L. Koller, Bonnie Slovis, et al.. (1997). Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31–32. Nature Genetics. 15(3). 277–280. 201 indexed citations
20.
Barg, Neil L., Lisa Wheeler, C. J. Thomson, et al.. (1990). Novel Dihydrofolate Reductases Isolated from Epidemic Strains of Trimethoprim/Sulfamethoxazole-Resistant Shigella sonnei. The Journal of Infectious Diseases. 162(2). 466–473. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Morganti Breakdown of academic impact, for papers by Michael V. Di Maria Breakdown of academic impact, for papers by Vladimir Y. Bogdanov Breakdown of academic impact, for papers by Yoichi Kameda Breakdown of academic impact, for papers by Marc Hilhorst Breakdown of academic impact, for papers by John D. Bonnet Breakdown of academic impact, for papers by Eva Honsová Breakdown of academic impact, for papers by Sylvia Bellucci Breakdown of academic impact, for papers by J L Francis Breakdown of academic impact, for papers by C Glanzmann
Rankless by CCL
2026